LNG exporter Venture Global slashes IPO price range despite President Trump’s pro-energy push
Venture Global is now seeking a more reasonable valuation of about $65 billion, versus earlier plans for about $110 billion.
S&P 500 is testing all-time high: 'Expect some sort of consolidation'
The S&P 500 is on track for its first record close since Dec. 6. Traders should beware of chasing the move, said Jonathan ...
For federal workers, Trump’s return-to-office order amounts to an unwelcome pay cut
The approaching return to full-time in-person work will cost remote and hybrid workers hundreds, if not thousands, of dollars ...
GE Vernova’s stock heads for a record as revenue missed, but outlook kept intact
GE Vernova’s stock was rallying toward a sixth straight record close Wednesday as optimism over how the power business will ...
Americans buy $900 billion a year in stuff from Mexico and Canada. Tariffs could affect these prices the most.
Americans buy $900 billion a year in food, cars, TVs, toys, appliances and other goods from Mexico and Canada. The cost of ...
Travelers withstands higher catastrophe losses as underwriting fuels earnings beat
Travelers Cos. executives confirm the Los Angeles wildfires will have a material impact on the insurer’s first-quarter ...
Is this marriage for love — or money? ‘I always recommend a prenup.’
Remarriages fail more often than first marriages. While close to half of first marriages in the U.S. end in divorce, 67% of ...
Schwab’s stock lagged rivals such as Robinhood last year. Here’s why it could be a buy now.
Charles Schwab Corp. surprised investors with a fourth-quarter earnings beat on Tuesday, sending the stock higher. It was a ...
This is the No. 1 CD for January 2025
We analyzed “best CD” lists from 11 of the best-known financial sites to find the CDs that were recommended the most ...
P&G didn’t raise prices for first time in 6 years, and Q2 earnings still beat
Shares of Procter & Gamble Co. PG +0.37% powered up 2.8% in premarket trading Wednesday, after the consumer products giant’s ...
Medexus Pharma Shares Higher on FDA Approval for Grafapex
Shares were up 30% to 5.18 Canadian dollars Wednesday. Medexus will target a commercial launch in the first half of calendar 2025. The company believes product-level revenue in the U.S. has the ...
Stocks of companies reporting earnings are providing a net 50-point boost to the Dow
Earnings still matter, as the stocks of companies that are, on a net basis, accounting for nearly half of the Dow's gains. Travelers' stock was jumping $8.85 (3.7%) after Q4 results, to add about ...